Artelo Biosciences Inc - Warrants (18/06/2024)
ARTLW
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.31M
Close$
$2.41
42919.6% upside
Current Fair Value
42919.6% upsideUndervalued by 42919.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.31 Million |
|---|---|
| Enterprise Value | $-1,839,133.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.47 |
| Beta | 1.25 |
| Outstanding Shares | 2,712,000 |
Return
| Return on Equity | -253.57% |
|---|---|
| Return on Assets | -196.18% |
| Return on Invested Capital | -240.87% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | 0.33 |
| Price to Sales | - |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.15 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.03 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Artelo Biosciences Inc
3 employeesArtelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting lipid signaling pathways including the endocannabinoid system. Artelo is rap...